The Latin America, Middle East and Africa Electronic Data Capture Systems Market would witness market growth of 16.4% CAGR during the forecast period (2022-2028).
EDC systems are utilized in all facets of clinical research by organizations in the life sciences, which are typically referred to as the pharmaceutical industry, medical device manufacturing, and biotechnology. However, these systems are particularly beneficial for late-stage studies, pharmacovigilance, and post-market testing for security. It is a trade-off that many pharmaceutical developers must face with the emergence of an EDC to make the production of their pharmaceutical products: the start-up is relatively large, which has huge advantages over the course of the trial.
This is the trade-off that many pharmaceutical developers must make. As a consequence of this, the economy of an EDC has to be more than the expenses of installation while the test is being conducted. In addition, businesses are concerned well about initial installation expenses as well as the ongoing maintenance costs associated with storing data on-premises. In addition, businesses must be concerned about the costs of their employees as well as problems associated with downtime.
The already present level of competition, as well as the current state of the global economy, have hastened the implementation of cost-effective techniques that restructure company models. There are a few additional factors that are going to lead to the use of electronic data capture software services that are ultimately reducing the costs incurred by enterprises. These factors include the increasing shift of businesses toward the adoption of digital transformation and the acceleration of customer experience.
The provision of medical treatment is subject to regulation at both the federal and emirate levels of government in the UAE. The United Arab Emirates (UAE's) Ministry of Health and Prevention is the primary government agency charged with overseeing the country's healthcare sector. In order to attract international investment and increase industry standards for healthcare, the government of the UAE is easing some of the restrictions that have been in place. The government of the UAE has set a goal to attract more patients seeking medical care from other countries to the country. The growth of the healthcare business in the area would be beneficial to the development of the market in the region.
The Brazil market dominated the LAMEA Electronic Data Capture Systems Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $39.7 million by 2028.The Argentina market is experiencing a CAGR of 17% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 16.1% during (2022 - 2028).
Based on Component, the market is segmented into Services and Software. Based on End User, the market is segmented into CROs, Pharmaceutical & Biotechnology Firms, Hospitals/Healthcare providers, Medical Device Firms and Others. Based on Development Phase, the market is segmented into Phase III, Phase II, Phase I and Phase IV. Based on Delivery Mode, the market is segmented into Web & Cloud-based and On-premiseBased on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Oracle Corporation, IBM Corporation, Veeva Systems, Inc., IQVIA Holdings, Inc., Medidata Solutions, Inc. (Dassault Systems SE), OpenClinica, LLC, DATATRAK International, Inc., Clario, Castor EDC, and Calyx.
EDC systems are utilized in all facets of clinical research by organizations in the life sciences, which are typically referred to as the pharmaceutical industry, medical device manufacturing, and biotechnology. However, these systems are particularly beneficial for late-stage studies, pharmacovigilance, and post-market testing for security. It is a trade-off that many pharmaceutical developers must face with the emergence of an EDC to make the production of their pharmaceutical products: the start-up is relatively large, which has huge advantages over the course of the trial.
This is the trade-off that many pharmaceutical developers must make. As a consequence of this, the economy of an EDC has to be more than the expenses of installation while the test is being conducted. In addition, businesses are concerned well about initial installation expenses as well as the ongoing maintenance costs associated with storing data on-premises. In addition, businesses must be concerned about the costs of their employees as well as problems associated with downtime.
The already present level of competition, as well as the current state of the global economy, have hastened the implementation of cost-effective techniques that restructure company models. There are a few additional factors that are going to lead to the use of electronic data capture software services that are ultimately reducing the costs incurred by enterprises. These factors include the increasing shift of businesses toward the adoption of digital transformation and the acceleration of customer experience.
The provision of medical treatment is subject to regulation at both the federal and emirate levels of government in the UAE. The United Arab Emirates (UAE's) Ministry of Health and Prevention is the primary government agency charged with overseeing the country's healthcare sector. In order to attract international investment and increase industry standards for healthcare, the government of the UAE is easing some of the restrictions that have been in place. The government of the UAE has set a goal to attract more patients seeking medical care from other countries to the country. The growth of the healthcare business in the area would be beneficial to the development of the market in the region.
The Brazil market dominated the LAMEA Electronic Data Capture Systems Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $39.7 million by 2028.The Argentina market is experiencing a CAGR of 17% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 16.1% during (2022 - 2028).
Based on Component, the market is segmented into Services and Software. Based on End User, the market is segmented into CROs, Pharmaceutical & Biotechnology Firms, Hospitals/Healthcare providers, Medical Device Firms and Others. Based on Development Phase, the market is segmented into Phase III, Phase II, Phase I and Phase IV. Based on Delivery Mode, the market is segmented into Web & Cloud-based and On-premiseBased on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Oracle Corporation, IBM Corporation, Veeva Systems, Inc., IQVIA Holdings, Inc., Medidata Solutions, Inc. (Dassault Systems SE), OpenClinica, LLC, DATATRAK International, Inc., Clario, Castor EDC, and Calyx.
Scope of the Study
Market Segments Covered in the Report:
By Component
- Services
- Software
By End-user
- CROs
- Pharmaceutical & Biotechnology Firms
- Hospitals/Healthcare providers
- Medical Device Firms
- Others
By Development Phase
- Phase III
- Phase II
- Phase I
- Phase IV
By Delivery Mode
- Web & Cloud-based
- On-premise
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Oracle Corporation
- IBM Corporation
- Veeva Systems, Inc
- IQVIA Holdings, Inc
- Medidata Solutions, Inc. (Dassault Systems SE)
- OpenClinica, LLC
- DATATRAK International, Inc
- Clario
- Castor EDC
- Calyx
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Electronic Data Capture Systems Market, by Component
1.4.2 LAMEA Electronic Data Capture Systems Market, by End-user
1.4.3 LAMEA Electronic Data Capture Systems Market, by Development Phase
1.4.4 LAMEA Electronic Data Capture Systems Market, by Delivery Mode
1.4.5 LAMEA Electronic Data Capture Systems Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2018, Oct - 2022, Dec) Leading Players
3.3.3 Key Strategic Move: (Partnerships, Agreements and Collaboration : 2021, Sep - 2022, Nov) Leading Players
Chapter 4. LAMEA Electronic Data Capture Systems Market by Component
4.1 LAMEA Services Market by Country
4.2 LAMEA Software Market by Country
Chapter 5. LAMEA Electronic Data Capture Systems Market by End-user
5.1 LAMEA CROs Market by Country
5.2 LAMEA Pharmaceutical & Biotechnology Firms Market by Country
5.3 LAMEA Hospitals/Healthcare providers Market by Country
5.4 LAMEA Medical Device Firms Market by Country
5.5 LAMEA Others Market by Country
Chapter 6. LAMEA Electronic Data Capture Systems Market by Development Phase
6.1 LAMEA Phase III Market by Country
6.2 LAMEA Phase II Market by Country
6.3 LAMEA Phase I Market by Country
6.4 LAMEA Phase IV Market by Country
Chapter 7. LAMEA Electronic Data Capture Systems Market by Delivery Mode
7.1 LAMEA Web & Cloud-based Market by Country
7.2 LAMEA On-premise Market by Country
Chapter 8. LAMEA Electronic Data Capture Systems Market by Country
8.1 Brazil Electronic Data Capture Systems Market
8.1.1 Brazil Electronic Data Capture Systems Market by Component
8.1.2 Brazil Electronic Data Capture Systems Market by End-user
8.1.3 Brazil Electronic Data Capture Systems Market by Development Phase
8.1.4 Brazil Electronic Data Capture Systems Market by Delivery Mode
8.2 Argentina Electronic Data Capture Systems Market
8.2.1 Argentina Electronic Data Capture Systems Market by Component
8.2.2 Argentina Electronic Data Capture Systems Market by End-user
8.2.3 Argentina Electronic Data Capture Systems Market by Development Phase
8.2.4 Argentina Electronic Data Capture Systems Market by Delivery Mode
8.3 UAE Electronic Data Capture Systems Market
8.3.1 UAE Electronic Data Capture Systems Market by Component
8.3.2 UAE Electronic Data Capture Systems Market by End-user
8.3.3 UAE Electronic Data Capture Systems Market by Development Phase
8.3.4 UAE Electronic Data Capture Systems Market by Delivery Mode
8.4 Saudi Arabia Electronic Data Capture Systems Market
8.4.1 Saudi Arabia Electronic Data Capture Systems Market by Component
8.4.2 Saudi Arabia Electronic Data Capture Systems Market by End-user
8.4.3 Saudi Arabia Electronic Data Capture Systems Market by Development Phase
8.4.4 Saudi Arabia Electronic Data Capture Systems Market by Delivery Mode
8.5 South Africa Electronic Data Capture Systems Market
8.5.1 South Africa Electronic Data Capture Systems Market by Component
8.5.2 South Africa Electronic Data Capture Systems Market by End-user
8.5.3 South Africa Electronic Data Capture Systems Market by Development Phase
8.5.4 South Africa Electronic Data Capture Systems Market by Delivery Mode
8.6 Nigeria Electronic Data Capture Systems Market
8.6.1 Nigeria Electronic Data Capture Systems Market by Component
8.6.2 Nigeria Electronic Data Capture Systems Market by End-user
8.6.3 Nigeria Electronic Data Capture Systems Market by Development Phase
8.6.4 Nigeria Electronic Data Capture Systems Market by Delivery Mode
8.7 Rest of LAMEA Electronic Data Capture Systems Market
8.7.1 Rest of LAMEA Electronic Data Capture Systems Market by Component
8.7.2 Rest of LAMEA Electronic Data Capture Systems Market by End-user
8.7.3 Rest of LAMEA Electronic Data Capture Systems Market by Development Phase
8.7.4 Rest of LAMEA Electronic Data Capture Systems Market by Delivery Mode
Chapter 9. Company Profiles
9.1 Oracle Corporation
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Product Launches and Product Expansions:
9.1.5.3 Acquisition and Mergers:
9.1.6 SWOT Analysis
9.2 IBM Corporation
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Regional & Segmental Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.6 SWOT Analysis
9.3 Veeva Systems, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Regional Analysis
9.3.4 Research & Development Expenses
9.3.5 Recent strategies and developments:
9.3.5.1 Product Launches and Product Expansions:
9.4 IQVIA Holdings, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Recent strategies and developments:
9.4.4.1 Partnerships, Collaborations, and Agreements:
9.5 Medidata Solutions, Inc. (Dassault Systems SE)
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.5.2 Product Launches and Product Expansions:
9.6 OpenClinica, LLC
9.6.1 Company Overview
9.6.2 Recent strategies and developments:
9.6.2.1 Partnerships, Collaborations, and Agreements:
9.7 DATATRAK International, Inc.
9.7.1 Company Overview
9.7.2 Recent strategies and developments:
9.7.2.1 Product Launches and Product Expansions:
9.8 Clario
9.8.1 Company Overview
9.8.2 Recent strategies and developments:
9.8.2.1 Partnerships, Collaborations, and Agreements:
9.9 Castor EDC
9.9.1 Company Overview
9.9.2 Recent strategies and developments:
9.9.2.1 Product Launches and Product Expansions:
9.10. Calyx
9.10.1 Company Overview
Companies Mentioned
- Oracle Corporation
- IBM Corporation
- Veeva Systems, Inc.
- IQVIA Holdings, Inc.
- Medidata Solutions, Inc. (Dassault Systems SE)
- OpenClinica, LLC
- DATATRAK International, Inc.
- Clario
- Castor EDC
- Calyx
Methodology
LOADING...
